Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
03 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250603288322/en/ASCO-Report-of-Pioneering-Treatment-of-Lymphopenia-with-Significant-Overall-Survival-Benefit-in-Advanced-Pancreatic-Cancer
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527707769/en/ImmunityBio-Saudi-Arabias-Ministry-of-Investment-KFSHRC-and-KAIMRC-Sign-Strategic-Memorandum-of-Understanding-to-Launch-Cancer-BioShield-Platform-in-the-Middle-East
12 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250512481413/en/ImmunityBio-Reports-Doubled-Net-Revenue-and-150-Unit-Growth-in-Q1-2025-With-Continued-Strong-Sales-Momentum-in-First-Quarter-since-J-code
05 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250505409104/en/ImmunityBio-Requests-an-Urgent-Meeting-With-FDA-to-Address-the-Change-in-the-Agencys-Unambiguous-Guidance-on-Jan-2025-to-Submit-a-sBLA-for-NMIBC-BCG-Unresponsive-Papillary-Disease-Following-an-Inconsistent-Refusal-to-File-Letter-on-May-2-2025
28 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250428844244/en/Unmatched-Long-Term-Bladder-Preservation-for-36-Months-in-over-80-percent-of-Responders-with-ANKTIVA-Plus-BCG-in-BCG-Unresponsive-NMIBC-CIS-and-Papillary-Disease-Alone-Best-in-Disease-and-Best-in-Class-with-5-Year-Follow-Up
27 Apr 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/jj-aims-fundamentally-change-how-bladder-cancer-type-treated-immunitybio-plays-defense
ABOUT THIS PAGE